Loading data
NTESNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 16.11 bn USD | 14.43 bn USD | 14.57 bn USD | 13.99 bn USD |
| Cost of revenue | 5.75 bn USD | 5.41 bn USD | 5.69 bn USD | 6.34 bn USD |
| Gross profit | 10.35 bn USD | 9.02 bn USD | 8.88 bn USD | 7.65 bn USD |
| Research and development expense | 2.53 bn USD | 2.4 bn USD | 2.32 bn USD | 2.18 bn USD |
| Operating profit | 5.12 bn USD | 4.05 bn USD | 3.9 bn USD | 2.85 bn USD |
| Profit before tax | 5.84 bn USD | 4.89 bn USD | 4.8 bn USD | 3.52 bn USD |
| Income tax expense | 862.66 m USD | 748.21 m USD | 661.94 m USD | 729.55 m USD |
| Net income (reported basis) | 4.98 bn USD | 4.15 bn USD | 4.13 bn USD | 2.88 bn USD |
| Net income attributable to common shareholders | 4.83 bn USD | 4.07 bn USD | 4.14 bn USD | 2.95 bn USD |
| Basic earnings per share | 1.52 USD/share | 1.27 USD/share | 1.29 USD/share | 0.9 USD/share |
| Diluted earnings per share | 1.5 USD/share | 1.26 USD/share | 1.27 USD/share | 0.89 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.